Some interesting news just came out yesterday. It looks like J&J’s new anti-MRSA cephalosporin, ceftobiprole has been, once again, turned back by the FDA. See the story here: http://money.cnn.com/news/newsfeeds/articles/marketwire/0572888.htm Many of us had pretty high hopes for this antibiotic as …
Read more →One of the ideas behind creating this blog was to be able to keep readers apprised of any new, interesting papers published in the infectious diseases and microbiology literature I follow on a regular basis. For background I will tell …
Read more →Last week I was invited by Bret Ribotsky, DPM to participate in one of his “Meet the Masters” telephone conferences (www.podiatricsuccess.com). We had an interesting conversation covering topics such as my definition of “success”, the Journal of the APMA, and …
Read more →It has been about 2 weeks since my first post about ICAAC which has given me some time to ruminate a bit over the happenings there. I have always enjoyed this meeting because its emphasis on new antibiotic development, an …
Read more →With the news of the imminent release of the 3rd Edition tentatively scheduled for 9/25 it is time to update the blog. Over the next few days I hope to get a few more posts up covering some recent literature …
Read more →This new consensus document on the use of vancomycin in the treatment of MRSA is a MUST READ for anyone treating MRSA (which pretty much means anyone reading this post!). The document can be found on the Infectious Diseases Society …
Read more →